PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 92 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,031,000 | +40.8% | 232,128 | +73.3% | 0.06% | +60.0% |
| Q3 2019 | $1,442,000 | +470.0% | 133,969 | +571.8% | 0.04% | +600.0% |
| Q2 2019 | $253,000 | -62.5% | 19,943 | +14.6% | 0.01% | -66.7% |
| Q1 2019 | $675,000 | +36.6% | 17,400 | +249.6% | 0.02% | +36.4% |
| Q4 2017 | $494,000 | -40.0% | 4,977 | -77.5% | 0.01% | -45.0% |
| Q1 2017 | $823,000 | -46.6% | 22,131 | -55.9% | 0.02% | -63.6% |
| Q4 2016 | $1,542,000 | -64.0% | 50,235 | -21.5% | 0.06% | -58.3% |
| Q3 2016 | $4,289,000 | -24.9% | 63,967 | -12.5% | 0.13% | -2.2% |
| Q4 2015 | $5,713,000 | +110.0% | 73,142 | +180.0% | 0.14% | +70.9% |
| Q1 2014 | $2,720,000 | -26.5% | 26,120 | -68.7% | 0.08% | -21.0% |
| Q2 2013 | $3,703,000 | – | 83,458 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |